Detalhe da pesquisa
1.
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial.
Ann Oncol
; 26(6): 1254-1262, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862439
2.
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients.
Ann Oncol
; 26(3): 510-6, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25471333
3.
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes.
Br J Cancer
; 110(2): 375-83, 2014 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24366294
4.
Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications.
Br J Dermatol
; 171(2): 220-33, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641095
5.
Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis.
Br J Dermatol
; 170(1): 66-77, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24134623
6.
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer.
Br J Cancer
; 108(5): 1052-60, 2013 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23422754
7.
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.
Br J Cancer
; 108(6): 1358-67, 2013 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23470469
8.
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial.
Br J Cancer
; 109(9): 2453-61, 2013 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24091623
9.
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients.
Ann Oncol
; 23(12): 3091-3097, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22865782
10.
Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer.
Br J Cancer
; 104(9): 1472-7, 2011 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21468046
11.
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
Ann Oncol
; 22(3): 515-523, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20603440
12.
Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype.
Br J Cancer
; 103(4): 532-41, 2010 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20664596
13.
Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.
Br J Cancer
; 102(2): 276-84, 2010 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19953098
14.
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.
Br J Cancer
; 100(8): 1277-86, 2009 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19367284
15.
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.
Br J Cancer
; 100(6): 971-8, 2009 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19240722
16.
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.
Ann Oncol
; 20(4): 615-20, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19254941
17.
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.
Br J Cancer
; 98(9): 1500-7, 2008 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-18454159
18.
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype.
Br J Cancer
; 99(10): 1735-42, 2008 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18841156
19.
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial.
Eur J Cancer
; 99: 1-8, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29885375
20.
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
J Clin Oncol
; 18(7): 1399-411, 2000 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10735887